Literature DB >> 25425599

Routine kidney variables, glomerular filtration rate and urinary cystatin C in cats with diabetes mellitus, cats with chronic kidney disease and healthy cats.

Dominique Paepe1, Liesbeth Fe Ghys2, Pascale Smets2, Hervé P Lefebvre3, Siska Croubels4, Sylvie Daminet2.   

Abstract

OBJECTIVES: Diabetic kidney disease (DKD) is a frequent and serious complication in human diabetic patients, but data are limited in cats. This study was undertaken to assess whether diabetic cats are susceptible to DKD.
METHODS: Kidney function was compared between 36 cats with diabetes mellitus (DM), 10 cats with chronic kidney disease (CKD) and 10 age-matched healthy cats by measuring routine kidney variables (serum creatinine [sCreat], serum urea [sUrea], urine specific gravity [USG], urinary protein:creatinine ratio [UPC]), urinary cystatin C:creatinine ratio and glomerular filtration rate (GFR). Urinary cystatin C (uCysC) was measured with a human particle-enhanced nephelometric immunoassay, validated to measure feline cystatin C, in all but two diabetic cats. GFR was evaluated by exo-iohexol clearance in 17 diabetic cats, all cats with CKD and all healthy cats.
RESULTS: Diabetic cats had significantly (mean ± SD) lower sCreat (123 ± 38 vs 243 ± 80 µmol/l), sUrea (11 ± 3 vs 18 ± 7 mmol/l) and urinary cystatin C:creatinine ratio (6 ± 31 vs 173 ± 242 mg/mol), and a significantly higher USG (1.033 ± 0.012 vs 1.018 ± 0.006) and GFR (2.0 ± 0.7 vs 0.8 ± 0.3 ml/min/kg) compared with cats with CKD. Compared with healthy cats, diabetic cats only had significantly lower USG (1.033 ± 0.012 vs 1.046 ± 0.008). Proteinuria (UPC >0.4) was present in 39% of diabetic cats, in 30% of cats with CKD and in none of the healthy cats. However, the UPC did not differ statistically between the three groups. CONCLUSIONS AND RELEVANCE: Based on evaluation of routine kidney variables, GFR and uCysC as a tubular marker at a single time point, a major impact of feline DM on kidney function could not be demonstrated. © ISFM and AAFP 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25425599     DOI: 10.1177/1098612X14559788

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  6 in total

1.  Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.

Authors:  R Langhorn; I N Kieler; J Koch; L B Christiansen; L R Jessen
Journal:  J Vet Intern Med       Date:  2017-12-12       Impact factor: 3.333

2.  Assessment of the association between diabetes mellitus and chronic kidney disease in adult cats.

Authors:  Laura Pérez-López; Mauro Boronat; Carlos Melián; Pedro Saavedra; Yeray Brito-Casillas; Ana M Wägner
Journal:  J Vet Intern Med       Date:  2019-07-15       Impact factor: 3.333

Review 3.  Renal biomarkers in cats: A review of the current status in chronic kidney disease.

Authors:  Thirawut Kongtasai; Dominique Paepe; Evelyne Meyer; Femke Mortier; Sofie Marynissen; Lisa Stammeleer; Pieter Defauw; Sylvie Daminet
Journal:  J Vet Intern Med       Date:  2022-02-26       Impact factor: 3.333

4.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

5.  Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.

Authors:  L F E Ghys; D Paepe; H P Lefebvre; B S Reynolds; S Croubels; E Meyer; J R Delanghe; S Daminet
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

6.  Plasma symmetric dimethylarginine and creatinine concentrations and glomerular filtration rate in cats with normal and decreased renal function.

Authors:  Marleen Brans; Sylvie Daminet; Femke Mortier; Luc Duchateau; Hervé P Lefebvre; Dominique Paepe
Journal:  J Vet Intern Med       Date:  2020-12-04       Impact factor: 3.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.